Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer. [electronic resource]
- Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Mar 2009
- 353-8 p. digital
Publication Type: Journal Article
0167-8140
10.1016/j.radonc.2008.09.021 doi
Aged Aged, 80 and over Algorithms Humans Lymph Nodes--radiation effects Male Middle Aged Pelvis Prostatic Neoplasms--radiotherapy Radiation Dosage Radiotherapy Dosage Radiotherapy Planning, Computer-Assisted